التفاصيل البيبلوغرافية
العنوان: |
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer |
المؤلفون: |
Koca, Emre, Niravath, Polly Ann, Ensor, Joe, Patel, Tejal Amar, Li, Xiaoxian, Hemati, Pej, Wong, Helen, Qian, Wei, Boone, Toniva, Zhao, Jing, Ramshesh, Priya V., Cohen, Adam Louis, Murthy, Asha, Nair, Sindhu, Darcourt, Jorge German, Belcheva, Anna, Kaklamani, Virginia G., Chang, Jenny Chee Ning |
المساهمون: |
Takeda Pharmaceuticals U.S.A. |
المصدر: |
Breast Cancer Research and Treatment ; volume 188, issue 2, page 433-439 ; ISSN 0167-6806 1573-7217 |
بيانات النشر: |
Springer Science and Business Media LLC |
سنة النشر: |
2021 |
مصطلحات موضوعية: |
Cancer Research, Oncology |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1007/s10549-021-06214-7 |
DOI: |
10.1007/s10549-021-06214-7.pdf |
DOI: |
10.1007/s10549-021-06214-7/fulltext.html |
الإتاحة: |
https://doi.org/10.1007/s10549-021-06214-7Test |
حقوق: |
https://www.springer.com/tdmTest ; https://www.springer.com/tdmTest |
رقم الانضمام: |
edsbas.D2063C1A |
قاعدة البيانات: |
BASE |